Type 2 diabetes trials in Puerto Rico
16 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Where
- San Juan
- Age
- 18 years and over
- People
- 1,600 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07351058 · EU 2025-523106-32-00 - Phase 3Taking peopleHome Self-administration of Maridebart Cafraglutide With Autoinjector in Adults Living With Obesity or Overweight
- Where
- San Juan
- Age
- 18 years to 99 years
- People
- 230 worldwide
- Run by
- Amgen
See details and how to joinNCT07871409 - Phase 2Taking peopleA Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- Where
- Bayamón, San Juan
- Age
- 18 years to 75 years
- People
- 200 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06897475 · EU 2024-520328-27-00 - Phase 3Taking peopleA Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Where
- Caguas, Dorado
- Age
- 18 years and over
- People
- 1,035 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07282600 · EU 2025-523658-15-00 - Phase 3Taking peopleA Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- Where
- Bayamón, Guaynabo
- Age
- 18 years and over
- People
- 900 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07392190 · EU 2025-523659-73-00 - Phase 3Taking peopleA Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
- Where
- San Juan
- Age
- 18 years and over
- People
- 1,000 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07881458 · EU 2026-527230-31-00 - Phase 2Taking peopleA Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Where
- Dorado, Vega Baja
- Age
- 18 years and over
- People
- 120 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07783802 - Phase 3Not yet taking people in Puerto RicoA Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes
- Where
- Ponce, San Juan
- Age
- 18 years and over
- People
- 2,115 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07881432 · EU 2026-526047-34-00 - Phase 3Not yet taking people in Puerto RicoA Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
- Where
- Dorado, Ponce, San Juan
- Age
- 45 years to 64 years
- People
- 3,000 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07900633 · EU 2026-525919-14-00 - Phase 3Taking peopleA Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Where
- San Juan
- Age
- 18 years and over
- People
- 2,000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07662109 · EU 2025-523941-81-00 - Phase 3Taking peopleEASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Where
- Dorado, Ponce, San Juan
- Age
- 18 years and over
- People
- 11,800 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07064473 · EU 2025-521188-11-00 - Phase 2Taking peopleA Study Evaluating the Safety of Inavolisib and Fulvestrant With or Without Palbociclib in Participants With Advanced Breast Cancer (ABC) and Type 2 Diabetes
- Where
- Dorado
- Age
- 18 years and over
- People
- 40 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07748208 - Phase 3Taking peopleExtension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
- Where
- San Juan
- Age
- 18 years to 99 years
- People
- 950 worldwide
- Run by
- Amgen
See details and how to joinNCT07684144 · EU 2025-524788-19-00 - Phase 3Taking peopleA Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- Where
- Dorado, Vega Baja
- Age
- 18 years and over
- People
- 1,980 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07321886 · EU 2025-523657-34-00 - No phaseTaking peopleCulturally Adapted Dietary Clinical Trial in PR
- Where
- San Juan
- Age
- 30 years to 65 years
- People
- 250
- Run by
- Harvard School of Public Health (HSPH)
See details and how to joinNCT05962372 - No phaseTaking peopleImplementing Scalable, PAtient-centered, Team-based, Technology-enabled Care for Adults With Type 2 Diabetes (iPATH)
- Where
- San Juan
- Age
- 18 years and over
- People
- 119,680 worldwide
- Run by
- Stanford University
See details and how to joinNCT06251323